You are here:

NICE
NICE Guidance
Conditions and diseases
Cancer
Prostate cancer

Prostate cancer Products

A list of all our products on prostate cancer

Filter

Product type

Product typeGuidanceQuality standardsAdviceShared learning

Advice programme
1 selected

Advice programmeEvidence summariesMedtech innovation briefings

Status

StatusPublishedIn developmentAwaiting developmentTopic selection

Showing 1 product

Date | Sort by Title

Advice programme: Evidence summariesRemove ‘Advice programme: Evidence summaries’ filter

Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)
Product type:
Advice
Programme:
Evidence summary
Published:
5 January 2016